OCT New England (Outsourcing in Clinical Trials) 2024
Join us at OCT New England 2024, happening October 23-24 in Boston, MA!
Visit booth #33 to meet TFS’s experienced CRO team and explore our specialized clinical development and resourcing solutions designed to elevate your clinical research. We combine the full-service capabilities and global reach of a large CRO with the flexibility and personal approach only a mid-size CRO can deliver.
Why TFS?
Experience scientific and medical excellence across diverse therapeutic areas. Our seasoned professionals ensure solution-driven outcomes, allowing sponsors to concentrate on advancing clinical innovations. TFS CRO provides industry-leading capabilities in the following areas:
Our Experts
Contact us today to connect during the conference and discover how TFS can be your strategic CRO partner in clinical development. See you at OCT New England(Outsourcing in Clinical Trials) 2024!
Attend Our Presentation
- Thursday, October 24 at 11:30 AM
- Stream B: Clinical Technology & Innovation
- Leveraging Technology to Ease Patient Burden: The Right Solutions for Better Clinical Trials by Kris O’Brien, VP, Head of Oncology & Rare Diseases
In this session, you can expect to learn about:
- Discover the Technology Behind Patient-Centric Trials: Explore the cutting-edge tools that streamline trial processes and minimize patient burden, improving both retention and outcomes.
- The Smart Use of Tech in Clinical Trials: Learn how to strategically implement technology to enhance patient experiences without compromising data integrity or trial efficiency.
- Balancing Innovation with Human Touch: Understand when technology empowers clinical trials and when human intervention remains critical, ensuring the right blend for successful studies.
- Practical Insights on Reducing Patient Burden: Gain actionable insights into how technology can be applied to simplify patient participation, from remote monitoring to decentralized trial designs.
- Where Tech Truly Makes an Impact: Explore specific phases and aspects of clinical trials where technology transforms patient engagement and drives trial success.
About Our Presenter: Kris O'Brien
Kris O’Brien manages a global team of experts ranging from physicians to clinical specialists and is responsible for supporting the project delivery of all oncology and rare disease programs. Her diverse experience spans working with CROs, pharmaceutical companies, and academic institutions, with more than half of her career focusing on oncology and rare diseases. Kris’s extensive background includes leadership positions as Vice President of Operations, Executive Director of Strategy, and Head of Project Management, among other clinical roles across the industry.